Glaxo Holders Back Board in Face of Elliott Stake, Mail Reports
This article is for subscribers only.
Want the lowdown on European markets? In your inbox before the open, every day. Sign up here.
Three shareholders of GlaxoSmithKline Plc are backing the board as the U.K. pharmaceutical giant faces increasing pressure to speed-up a turnaround plan after activist investor Elliott Management Corp. bought a stake, the Mail on Sunday reported.